Product NDC: | 0409-3414 |
Proprietary Name: | Metoclopramide |
Non Proprietary Name: | METOCLOPRAMIDE HYDROCHLORIDE |
Active Ingredient(s): | 5 mg/mL & nbsp; METOCLOPRAMIDE HYDROCHLORIDE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-3414 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA073118 |
Marketing Category: | ANDA |
Start Marketing Date: | 19910117 |
Package NDC: | 0409-3414-01 |
Package Description: | 25 VIAL in 1 TRAY (0409-3414-01) > 2 mL in 1 VIAL |
NDC Code | 0409-3414-01 |
Proprietary Name | Metoclopramide |
Package Description | 25 VIAL in 1 TRAY (0409-3414-01) > 2 mL in 1 VIAL |
Product NDC | 0409-3414 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | METOCLOPRAMIDE HYDROCHLORIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19910117 |
Marketing Category Name | ANDA |
Labeler Name | Hospira, Inc. |
Substance Name | METOCLOPRAMIDE HYDROCHLORIDE |
Strength Number | 5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Dopamine D2 Antagonists [MoA],Dopamine-2 Receptor Antagonist [EPC] |